§2.9.8 · Chemicals › Nootropics

NSI-189

Acute: Lower riskDependency: Lower risk

Images

Quick reference

Routes

Oral

Form

Pill

Experience

Primary effects

Researched as a potential antidepressant and for treating cognitive impairment and neurodegeneration.

Peak character

Reported to have very subtle or unnoticeable effects, especially from a single experiment.

Negatives / side effects

No ill or negative effects reported in this single experience.

Aftereffects / comedown

No notable aftereffects or comedown from a single use.

Reagent testing

Adulterant detection: Research nootropic — no standard colorimetric test.

Experimental compound; no standard reagent test. COA from supplier recommended.

Source

Reference fields and narrative for NSI-189 extracted from The Drug Users Bible by Dominic Milton Trott (MxZero Publishing, 2022).

drugusersbible.com

Harm reduction notice

This platform provides educational and harm-reduction information adapted from public reference material. It does not endorse, encourage, or facilitate drug use. It is not medical advice. If you or someone near you may be in a medical emergency, contact local emergency services immediately.